Seraphim dedicates a substantial portion of its efforts to supporting the development of products and program transformation for the public health sector, especially in women’s health and international sectors. The Seraphim Conceptra^SM service provides drug development and commercialization as well as services, especially for the reproductive health, family planning and well being of disadvantaged women. This service is committed to assuring the creation and access to providing safe, effective and affordable contraceptives for all women.

The Seraphim Conceptra service has a proven track record in comprehensive product development and strategy for the public health markets. With years of experience in product development, due diligence and business consulting, Seraphim’s methods drive comprehensive insights and analyses that deliver specific decision points, meaningful benchmarks and actionable implementation plans.